Thomas Hadley

Visionary
DISC Type : Ds

Board Member at Teach For America, NJ

Florham Park, New Jersey, United States

Overview

Thomas Hadley is a seasoned pharmaceutical executive, currently President and CEO of Thoclor US, Inc. He recently led UTILITY therapeutics to a major success, securing the first FDA approval for a new UTI antibiotic in 20 years and overseeing the companys acquisition. Colleagues describe him as strategic, creative, and hands-on.

Beyond his corporate leadership, Thomas is dedicated to community impact, serving as a Board Member for Teach For America in New Jersey. This role reflects his commitment to supporting educational initiatives and contributing to local community development.

He led the development and FDA approval of PIVYA, the first new antibiotic for uncomplicated urinary tract infections in over two decades.

Personality Overview

Direct & Assertive

Risk Tolerant

Objective Evaluator

Reading between the lines and seeing beyond your words comes naturally to them.  They might take some time to make their mind up but once they do, they don't change it easily. They exhibit a rare combination of being result-oriented but patient at the same time.

Topics They Care About

Antibiotic Development
He recently led UTILITY therapeutics to a successful FDA approval and subsequent acquisition for PIVYA, a novel antibiotic for uncomplicated urinary tract infections.
Antimicrobial Resistance
He has publicly posted about his concern for the future of antibiotics and the significant threat posed by multi-drug resistant bacterial infections.
Pharmaceutical Commercialization
His career highlights a deep expertise in market strategy and business development, culminating in the successful acquisition of UTILITY therapeutics by Alembic Pharmaceuticals.

Media Appearances

Thomas has no verified media appearances

Work History

10-2025
Board Member at Teach For America, NJ
8-2025
President and CEO, Founder at Thoclor US, Inc
2-2021 - 7-2025
Board Member at Antimicrobials Working Group
7-2020 - 7-2025
President & CEO/Board Member at UTILITY therapeutics
10-2019 - 7-2020
Vice President, Market Strategy - Head of Market Development at EyePoint Pharmaceuticals

Education

1986 - 1990
BS from Seton Hall University
1980 - 1984
High School from Delbarton

More Information

Social Presence :

Prographics :

Exp : 28 Location : Florham Park, New Jersey, United States Job Level : Leadership Designation : Board Member at Teach For America, NJ
URL has been copied!

Insights For Selling To Thomas

During A Call Or A Meeting

DO's

  • You can spend time on BANT (or other qualification methodology) but keep it to the point
  • During followups, use phone or text if needed, they should be fine
  • Suggest clear next steps with confidence, don't be vague or hesitant

DONT's

  • Avoid putting conscious effort into relationship-building
  • Don't take their patience for granted, avoid long-winding sermons
  • Don't go over them unless you are left with no other option

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Thomas is

  • Strong proof of impact and their conviction will matter the most, but they wouldn't want to act unilaterally either
  • Will you ever get a clear answer from Thomas

  • They will say no if they are not convinced but you will have to prompt them.

Insights For Deal Planning

    How fast (or slow) will Thomas move?

  • They will want to understand things well but can move fast once they have a clear picture.
  • Can Thomas take some risk or not?

  • They have good risk tolerance but are likely to think it through once or twice.

You And Thomas

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.